Rocket Pharmaceuticals (RCKT) Short Interest Ratio & Short Volume → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free RCKT Stock Alerts $20.94 -0.48 (-2.24%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rocket Pharmaceuticals Short Interest DataCurrent Short Interest9,990,000 sharesPrevious Short Interest9,840,000 sharesChange Vs. Previous Month+1.52%Dollar Volume Sold Short$236.36 millionShort Interest Ratio14.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares90,780,000 sharesPercentage of Shares Shorted11.00%Today's Trading Volume1,081,524 sharesAverage Trading Volume695,607 sharesToday's Volume Vs. Average155% Short Selling Rocket Pharmaceuticals ? Sign up to receive the latest short interest report for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRCKT Short Interest Over TimeRCKT Days to Cover Over TimeRCKT Percentage of Float Shorted Over Time Ad Daily Strike Alliance🚀 Tap into this explosive trade opportunity asapI learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…Go here to see how you can exploit my next “Calendar Stock”. Rocket Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20249,990,000 shares $236.36 million +1.5%N/A14.6 $23.66 4/30/20249,840,000 shares $211.76 million -10.6%N/A13.5 $21.52 4/15/202411,000,000 shares $264.11 million +4.6%N/A15.3 $24.01 3/31/202410,520,000 shares $283.41 million +2.7%N/A14.7 $26.94 3/15/202410,240,000 shares $274.53 million +2.8%N/A13.6 $26.81 2/29/20249,960,000 shares $291.83 million +8.3%N/A12 $29.30 Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20249,200,000 shares $280.78 million +8.9%N/A11.3 $30.52 1/31/20248,450,000 shares $242.77 million +2.4%N/A10.4 $28.73 1/15/20248,250,000 shares $236.03 million -4.2%N/A9.3 $28.61 12/31/20238,610,000 shares $258.04 million -6.5%N/A9.7 $29.97 12/15/20239,210,000 shares $260.74 million +0.9%N/A10 $28.31 11/30/20239,130,000 shares $213.00 million +0.4%N/A6.7 $23.33 11/15/20239,090,000 shares $198.53 million +0.4%N/A7 $21.84 10/31/20239,050,000 shares $163.81 million +0.7%N/A7.2 $18.10 10/15/20238,990,000 shares $157.77 million -6.5%N/A7.6 $17.55 9/30/20239,610,000 shares $196.91 million +6.7%N/A8.3 $20.49 9/15/20239,010,000 shares $211.28 million +24.5%N/A8.2 $23.45 8/31/20237,240,000 shares $113.31 million -6.2%N/A12 $15.65 8/15/20237,720,000 shares $125.37 million -1.0%N/A11.9 $16.24 7/31/20237,800,000 shares $140.79 million -2.1%N/A11.6 $18.05 7/15/20237,970,000 shares $157.17 million -2.9%N/A11.6 $19.72 6/30/20238,210,000 shares $163.13 million -1.9%N/A11.8 $19.87 6/15/20238,370,000 shares $190.42 million +6.0%N/A10.9 $22.75 5/31/20237,900,000 shares $165.35 million -2.5%N/A9.7 $20.93 5/15/20238,100,000 shares $176.34 million +0.9%N/A9.8 $21.77 4/30/20238,030,000 shares $143.90 million -2.3%N/A9.6 $17.92 4/15/20238,220,000 shares $146.64 million -9.3%N/A9.7 $17.84 3/31/20239,060,000 shares $155.20 million +1.5%N/A10.5 $17.13 3/15/20238,930,000 shares $160.83 million +7.5%N/A9.5 $18.01 2/28/20238,310,000 shares $159.64 million +9.9%N/A9.2 $19.21 2/15/20237,560,000 shares $148.33 million +11.0%N/A8.6 $19.62 1/31/20236,810,000 shares $147.98 million -8.1%N/A7.5 $21.73 1/15/20237,410,000 shares $165.76 million +5.3%N/A8.1 $22.37 12/30/20227,040,000 shares $137.77 million +0.1%N/A7.7 $19.57 12/15/20227,030,000 shares $154.80 million -7.9%N/A6.8 $22.02 11/30/20227,630,000 shares $144.05 million -2.3%N/A7.6 $18.88 11/15/20227,810,000 shares $161.67 million -16.9%N/A7.8 $20.70 10/31/20229,400,000 shares $175.40 million -0.5%N/A9.7 $18.66 10/15/20229,450,000 shares $154.41 million -16.4%15.5%9.7 $16.34 9/30/202211,300,000 shares $180.35 million -3.9%18.5%11.7 $15.96This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 9/15/202211,760,000 shares $183.22 million +8.3%19.2%13.5 $15.58 8/31/202210,860,000 shares $167.35 million +1.1%17.8%14.2 $15.41 8/15/202210,740,000 shares $196.76 million +18.9%17.6%13.1 $18.32 7/31/20229,030,000 shares $130.94 million +5.2%14.8%9.8 $14.50 7/15/20228,580,000 shares $138.31 million +4.0%14.1%9.7 $16.12 6/30/20228,250,000 shares $113.52 million +4.2%13.6%9.7 $13.76 6/15/20227,920,000 shares $86.96 million -4.6%13.0%10.2 $10.98 5/31/20228,300,000 shares $98.36 million +10.1%13.7%12 $11.85 5/15/20227,540,000 shares $68.54 million -0.3%12.4%12.9 $9.09 4/30/20227,560,000 shares $77.72 million -12.6%12.6%15.2 $10.28 4/15/20228,650,000 shares $117.29 million -1.3%14.5%18.3 $13.56 3/31/20228,760,000 shares $138.93 million +3.8%14.7%19.2 $15.86 3/15/20228,440,000 shares $116.30 million +2.1%14.1%15.7 $13.78 2/28/20228,270,000 shares $147.29 million +1.2%14.0%15.2 $17.81 2/15/20228,170,000 shares $163.40 million +4.6%13.8%15.2 $20.00 1/31/20227,810,000 shares $129.96 million -9.2%13.8%14.5 $16.64 1/15/20228,600,000 shares $161.42 million +9.3%14.1%17 $18.77 12/31/20217,870,000 shares $171.80 million -2.6%12.9%16.9 $21.83 12/15/20218,080,000 shares $186.73 million +4.5%13.2%20.6 $23.11 11/30/20217,730,000 shares $188.84 million +0.7%12.6%22.2 $24.43 11/15/20217,680,000 shares $198.91 million -2.5%12.5%20.8 $25.90 10/29/20217,880,000 shares $234.11 million +0.9%12.8%20 $29.71 10/15/20217,810,000 shares $218.06 million -3.6%12.7%18.4 $27.92 9/30/20218,100,000 shares $242.11 million +2.4%13.1%17.6 $29.89 9/15/20217,910,000 shares $269.34 million +0.1%12.8%16.9 $34.05 8/31/20217,900,000 shares $270.26 million +2.3%12.8%17.2 $34.21 8/13/20217,720,000 shares $230.98 million -3.7%12.7%18.7 $29.92 7/30/20218,020,000 shares $287.28 million +5.3%13.2%20.4 $35.82 7/15/20217,620,000 shares $326.90 million -0.4%12.6%21.2 $42.90 6/30/20217,650,000 shares $338.82 million -4.0%12.6%21.8 $44.29 6/15/20217,970,000 shares $370.61 million -1.1%13.1%20.1 $46.50 5/28/20218,060,000 shares $342.55 million -1.0%13.3%18.6 $42.50 5/14/20218,140,000 shares $333.25 million +2.3%N/A17.3 $40.94 4/30/20217,960,000 shares $368.15 million -3.2%N/A16 $46.25 4/15/20218,220,000 shares $357.82 million -6.7%N/A16.7 $43.53 3/31/20218,810,000 shares $381.83 million +7.2%N/A17.3 $43.34 3/15/20218,220,000 shares $440.76 million -0.4%N/A15.7 $53.62 2/26/20218,250,000 shares $427.85 million +0.7%N/A11.2 $51.86 2/12/20218,190,000 shares $489.11 million -1.3%N/A11.2 $59.72 1/29/20218,300,000 shares $453.01 million +0.7%N/A11.5 $54.58 1/15/20218,240,000 shares $480.97 million +0.1%N/A11.9 $58.37 12/31/20208,230,000 shares $461.29 million -10.8%N/A12.3 $56.05 12/15/20209,230,000 shares $517.53 million +1.5%N/A14.8 $56.07 11/30/20209,090,000 shares $291.24 million -0.6%N/A19.9 $32.04 11/15/20209,140,000 shares $292.21 million -5.8%N/A30.3 $31.97 10/30/20209,700,000 shares $279.65 million +0.6%N/A35.5 $28.83 10/15/20209,640,000 shares $268.76 million +0.8%N/A34.6 $27.88 9/30/20209,560,000 shares $218.54 million +0.5%N/A32 $22.86 9/15/20209,510,000 shares $230.81 million +0.4%N/A25.9 $24.27 8/31/20209,470,000 shares $242.15 million -0.3%N/A23.1 $25.57This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 8/14/20209,500,000 shares $261.16 million +2.6%N/A22.1 $27.49 7/31/20209,260,000 shares $217.89 million +0.3%N/A21.1 $23.53 7/15/20209,230,000 shares $215.06 million +4.5%N/A20.6 $23.30 6/30/20208,830,000 shares $186.22 million +6.5%N/A19.8 $21.09 6/15/20208,290,000 shares $161.49 million -1.1%N/A20.8 $19.48 5/29/20208,380,000 shares $157.63 million +2.7%N/A20.4 $18.81 5/15/20208,160,000 shares $161.89 million +0.5%N/A18.7 $19.84 4/30/20208,120,000 shares $120.18 million -1.8%N/A18.5 $14.80 4/15/20208,270,000 shares $128.43 million +7.1%N/A19.6 $15.53 3/31/20207,720,000 shares $134.02 million +2.1%N/A18.3 $17.36 3/13/20207,560,300 shares $120.06 million +6.5%N/A14.1 $15.88 2/28/20207,100,000 shares $96.13 million -0.4%N/A15.4 $13.54 2/14/20207,130,000 shares $130.19 million +1.1%N/A16.7 $18.26 1/31/20207,050,000 shares $143.12 million -3.7%N/A17.3 $20.30 1/15/20207,320,000 shares $171.80 million +0.4%N/A19.2 $23.47 12/31/20197,290,000 shares $157.61 million -0.6%N/A19.6 $21.62 11/29/20197,370,000 shares $153.59 million +3.4%15.6%27.4 $20.84 8/15/20196,641,900 shares $77.25 million -0.1%15.8%19 $11.63 RCKT Short Interest - Frequently Asked Questions What is Rocket Pharmaceuticals' current short interest? Short interest is the volume of Rocket Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 9,990,000 shares of RCKT short. Learn More on Rocket Pharmaceuticals' current short interest. What is a good short interest ratio for Rocket Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCKT shares currently have a short interest ratio of 15.0. Learn More on Rocket Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rocket Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rocket Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Rocket Pharmaceuticals' short interest increasing or decreasing? Rocket Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totaling 9,990,000 shares, an increase of 1.5% from the previous total of 9,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rocket Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Rocket Pharmaceuticals: Amphastar Pharmaceuticals, Inc. (10.66%), Amneal Pharmaceuticals, Inc. (2.76%), Zai Lab Limited (3.31%), Catalyst Pharmaceuticals, Inc. (7.86%), Agios Pharmaceuticals, Inc. (10.97%), Vera Therapeutics, Inc. (15.46%), Galapagos NV (2.43%), Protagonist Therapeutics, Inc. (5.92%), Geron Co. (9.09%), Deciphera Pharmaceuticals, Inc. (7.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Rocket Pharmaceuticals stock? Short selling RCKT is an investing strategy that aims to generate trading profit from Rocket Pharmaceuticals as its price is falling. RCKT shares are trading down $0.48 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rocket Pharmaceuticals? A short squeeze for Rocket Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RCKT, which in turn drives the price of the stock up even further. How often is Rocket Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCKT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Amphastar Pharmaceuticals Short Squeeze Amneal Pharmaceuticals Short Squeeze Zai Lab Short Squeeze Catalyst Pharmaceuticals Short Squeeze Agios Pharmaceuticals Short Squeeze Vera Therapeutics Short Squeeze Galapagos Short Squeeze Protagonist Therapeutics Short Squeeze Geron Short Squeeze Deciphera Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RCKT) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.